|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Equity-based compensation expense | |||||
| Revaluation of contingent liabilities | |||||
| Impairment of intangible assets | |||||
| Unrealized gain on investments in securities | |||||
| Gain on investments in securities | |||||
| Change in TRA liability | |||||
| Amortization of capitalized financing costs, net of premium accretion | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of subsidiaries | |||||
| Provision for bad debts | |||||
| Deferred income taxes | |||||
| Unrealized foreign exchange losses | |||||
| Other noncash items | |||||
| Change in operating assets and liabilities | |||||
| Increase (Decrease) In Settlement Activity, Net | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Inventory | |||||
| Capitalized customer acquisition costs | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Payments on contingent liabilities in excess of initial fair value | |||||
| Right-of-use assets and lease liabilities, net | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Acquisitions, net of cash acquired | |||||
| Acquisition of equipment to be leased | |||||
| Capitalized software development costs | |||||
| Acquisition of property, plant and equipment | |||||
| Deposits with sponsor bank, net | |||||
| Residual commission buyouts | |||||
| Proceeds from sale of subsidiaries | |||||
| Purchase of intangible assets | |||||
| Proceeds from sale of investments in securities | |||||
| Investments in securities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from long-term debt | |||||
| Proceeds from preferred stock | |||||
| Repayment of debt | |||||
| Deferred financing costs | |||||
| Settlement line of credit | |||||
| Settlement activity, net | |||||
| Proceeds from common stock | |||||
| Acquisition of noncontrolling interests | |||||
| Repurchases of Class A common stock | |||||
| Payments for withholding tax related to vesting of restricted stock units | |||||
| Payments of preferred dividends | |||||
| Payments on contingent liabilities | |||||
| Distributions to noncontrolling interests | |||||
| Net change in bank deposits | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash - beginning of period | |||||
| Cash and cash equivalents and restricted cash - end of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
Loading...